Estudio de MK-4830 como monoterapia y en combinación con pembrolizumab en participantes con tumores sólidos avanzados
This study consists of several parts: dose escalation, dose expansion, dose expansion in Chinese participants residing in China, and coformulation. Dose escalation is to evaluate the safety, tolerability, and preliminary efficacy